Cargando…

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension

Objective: Abnormal glutamatergic neurotransmission is implicated in the pathophysiology of autism spectrum disorder (ASD). In this study, the safety, tolerability, and efficacy of the glutamatergic N-methyl-d-aspartate (NMDA) receptor antagonist memantine (once-daily extended-release [ER]) were inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aman, Michael G., Findling, Robert L., Hardan, Antonio Y., Hendren, Robert L., Melmed, Raun D., Kehinde-Nelson, Ola, Hsu, Hai-An, Trugman, Joel M., Palmer, Robert H., Graham, Stephen M., Gage, Allyson T., Perhach, James L., Katz, Ephraim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510039/ https://www.ncbi.nlm.nih.gov/pubmed/26978327 http://dx.doi.org/10.1089/cap.2015.0146

Ejemplares similares

Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies
por: Hardan, Antonio Y, et al.
Publicado: (2019)

Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver’s Quality of Life
por: Schroder, Carmen M., et al.
Publicado: (2019)

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
por: Grossberg, George T., et al.
Publicado: (2013)

Biomarkers in Autism
por: Goldani, Andre A. S., et al.
Publicado: (2014)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Pharmacokinetics of memantine in rats and mice
por: Beconi, Maria G., et al.
Publicado: (2012)

A Review of Complementary and Alternative Treatments for Autism Spectrum Disorders
por: Lofthouse, Nicholas, et al.
Publicado: (2012)

Pharmacotherapy of emotional and behavioral symptoms associated with autism spectrum disorder in children and adolescents
por: Stepanova, Ekaterina, et al.
Publicado: (2017)

Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
por: Goldman, Robert, et al.
Publicado: (2017)

Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
por: Veerman, S. R. T., et al.
Publicado: (2016)

The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects
por: Trotman, Melissa, et al.
Publicado: (2015)

Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study
por: Mease, Philip J, et al.
Publicado: (2014)

A Pilot Randomized Controlled Trial of Omega-3 Fatty Acids for Autism Spectrum Disorder
por: Bent, Stephen, et al.
Publicado: (2010)

Efficacy of Memantine as Adjunct Therapy for Autism Spectrum Disorder in Children Aged <14 Years
por: Karahmadi, Mojgan, et al.
Publicado: (2018)

Memantine as an Augmentation Therapy for Anxiety Disorders
por: Schwartz, Thomas L., et al.
Publicado: (2012)

Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder
por: Bangerter, Abi, et al.
Publicado: (2017)

Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer’s Disease in the Absence of Memantine(1)
por: Thompson, Richard E., et al.
Publicado: (2022)

Pharmacodynamics of Memantine: An Update
por: Rammes, G, et al.
Publicado: (2008)

Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
por: Hough, David, et al.
Publicado: (2023)

A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up
por: Findling, Robert L., et al.
Publicado: (2020)

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
por: Fox, Chris, et al.
Publicado: (2012)

Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study
por: Lee, Jung Goo, et al.
Publicado: (2012)

Memantine add on to citalopram in elderly patients with depression: A double-blind placebo-controlled study
por: Omranifard, Victoria, et al.
Publicado: (2014)

Is memantine a potential therapeutic for Rett syndrome?
por: Bello, Olivia, et al.
Publicado: (2013)

Crystal structure of memantine–carboxyborane
por: Ayudhya, Theppawut I., et al.
Publicado: (2019)

Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder
por: Bangerter, Abigail, et al.
Publicado: (2019)

Pancreatic Replacement Therapy for Maladaptive Behaviors in Preschool Children With Autism Spectrum Disorder
por: Pearson, Deborah A., et al.
Publicado: (2023)

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder
por: Durgam, Suresh, et al.
Publicado: (2018)

Critics on "Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study"
por: Pae, Chi-Un
Publicado: (2013)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder
por: Atkinson, Sarah, et al.
Publicado: (2018)

The effects of memantine on prepulse inhibition
por: Swerdlow, NR, et al.
Publicado: (2009)

Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019)

Gene expression in blood is associated with risperidone response in children with autism spectrum disorders
por: Lit, Lisa, et al.
Publicado: (2011)

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer’s disease: post-hoc analysis of a randomized placebo-controlled study
por: Hager, Klaus, et al.
Publicado: (2016)

A Comparative Study on the Efficacy of Oral Memantine and Placebo for Acute Postoperative Pain in Patients Undergoing Dacryocystorhinostomy (DCR)
por: Rahimzadeh, Poupak, et al.
Publicado: (2017)

The Therapeutic effect of Memantine through the Stimulation of Synapse Formation and Dendritic Spine Maturation in Autism and Fragile X Syndrome
por: Wei, Hongen, et al.
Publicado: (2012)

Review: The Autistic Brain: Thinking Across the Spectrum
por: Findling, Robert L.
Publicado: (2013)

51.1 A QUALITATIVE ANALYSIS: THE EXPERIENCE OF PARENTS OF CHILDREN WITH AUTISM SPECTRUM DISORDER DURING THE COVID-19 PANDEMIC
por: Parenteau, China I., et al.
Publicado: (2020)

A systematic review and meta-analysis of the benefits of a gluten-free diet and/or casein-free diet for children with autism spectrum disorder
por: Quan, Liuliu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qk0j3sljor716ffvsgh03mvjof